Copeland Capital Management LLC Has $18.28 Million Stake in U.S. Physical Therapy, Inc. (USPH)
Copeland Capital Management LLC grew its position in U.S. Physical Therapy, Inc. (NYSE:USPH) by 6.7% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 174,084 shares of the company’s stock after buying an additional 10,902 shares during the quarter. Copeland Capital Management LLC’s holdings in U.S. Physical Therapy were worth $18,284,000 as of its most recent SEC filing.
Several other large investors have also recently modified their holdings of the company. Kayne Anderson Rudnick Investment Management LLC increased its position in U.S. Physical Therapy by 91.3% during the 4th quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,391,781 shares of the company’s stock worth $142,449,000 after purchasing an additional 664,101 shares in the last quarter. BlackRock Inc. increased its position in U.S. Physical Therapy by 7.5% during the 4th quarter. BlackRock Inc. now owns 2,096,916 shares of the company’s stock worth $214,617,000 after purchasing an additional 146,642 shares in the last quarter. Bank of America Corp DE increased its position in U.S. Physical Therapy by 120.8% during the 4th quarter. Bank of America Corp DE now owns 117,114 shares of the company’s stock worth $11,987,000 after purchasing an additional 64,065 shares in the last quarter. Morgan Stanley increased its position in U.S. Physical Therapy by 80.4% during the 3rd quarter. Morgan Stanley now owns 96,651 shares of the company’s stock worth $11,463,000 after purchasing an additional 43,074 shares in the last quarter. Finally, Vanguard Group Inc increased its position in U.S. Physical Therapy by 5.9% during the 3rd quarter. Vanguard Group Inc now owns 767,401 shares of the company’s stock worth $91,014,000 after purchasing an additional 43,050 shares in the last quarter. Institutional investors own 99.58% of the company’s stock.
USPH traded up $0.44 during trading on Wednesday, reaching $113.34. 82,714 shares of the company’s stock were exchanged, compared to its average volume of 84,251. U.S. Physical Therapy, Inc. has a one year low of $85.45 and a one year high of $129.65. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.89 and a quick ratio of 1.89. The firm has a market capitalization of $1.40 billion, a price-to-earnings ratio of 42.77, a PEG ratio of 3.44 and a beta of 1.13.
The firm also recently announced a quarterly dividend, which was paid on Friday, April 19th. Shareholders of record on Wednesday, March 20th were issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.95%. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.23. The ex-dividend date was Tuesday, March 19th. U.S. Physical Therapy’s payout ratio is presently 40.75%.
In other news, Director Harry S. Chapman acquired 950 shares of U.S. Physical Therapy stock in a transaction dated Monday, March 18th. The shares were bought at an average cost of $105.33 per share, with a total value of $100,063.50. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Kathleen A. Gilmartin acquired 500 shares of U.S. Physical Therapy stock in a transaction dated Friday, March 29th. The stock was purchased at an average cost of $105.17 per share, for a total transaction of $52,585.00. Following the completion of the purchase, the director now owns 2,500 shares in the company, valued at approximately $262,925. The disclosure for this purchase can be found here. Insiders have sold a total of 9,754 shares of company stock worth $1,045,501 over the last three months. Insiders own 2.50% of the company’s stock.
A number of equities analysts recently issued reports on USPH shares. TheStreet upgraded shares of U.S. Physical Therapy from a “c+” rating to a “b” rating in a research report on Friday, March 8th. Zacks Investment Research lowered shares of U.S. Physical Therapy from a “buy” rating to a “hold” rating in a report on Saturday, February 9th. William Blair initiated coverage on shares of U.S. Physical Therapy in a report on Thursday, March 7th. They set an “outperform” rating and a $106.61 target price on the stock. Finally, ValuEngine lowered shares of U.S. Physical Therapy from a “strong-buy” rating to a “buy” rating in a report on Wednesday, March 6th. Five equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. U.S. Physical Therapy has an average rating of “Hold” and an average price target of $111.90.
ILLEGAL ACTIVITY WARNING: This piece was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another site, it was stolen and republished in violation of international trademark and copyright law. The original version of this piece can be viewed at https://www.thecerbatgem.com/2019/04/24/copeland-capital-management-llc-has-18-28-million-stake-in-u-s-physical-therapy-inc-usph.html.
U.S. Physical Therapy Profile
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Featured Article: What is a Swap?
Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH).
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.